e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Tuberculosis: public health and primary prevention
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
H1- and H56- subunit vaccines against TB - an overview of the clinical development
M. Ruhwald, E. M. Agger, S. T. Hoff, P. L. Andersen (Copenhagen, Denmark)
Source:
International Congress 2014 – Tuberculosis: public health and primary prevention
Session:
Tuberculosis: public health and primary prevention
Session type:
Oral Presentation
Number:
4477
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Ruhwald, E. M. Agger, S. T. Hoff, P. L. Andersen (Copenhagen, Denmark). H1- and H56- subunit vaccines against TB - an overview of the clinical development. Eur Respir J 2014; 44: Suppl. 58, 4477
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Evolution of TB in BCG unimmunized children
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016
Effectiveness of tuberculosis detection using a skin test with allergen recombinant (CFP-10-ESAT-6) in children
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
The protective effect of BCG vaccination against mycobacterium tuberculosis infection in children: A systematic review
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014
Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015
Detection TB infection using a skin tests with tuberculin and allergen recombinant (CFP-10-ESAT-6) in children and adolescents in Moscow in 2015
Source: International Congress 2016 – Latent tuberculosis infection
Year: 2016
Features of pulmonary tuberculosis in migrants
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015
Experience of skin test application using tuberculosis recombinant allergen (Diaskintest) in tuberculosis diagnostics of children
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
Detection of tuberculosis in children
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
Tuberculosis (TB) and depression
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
The particularities of new cases of tuberculosis at homeless people
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
BCG vaccination in childhood is not related to pulmonary immunity against
M. tuberculosis
in adults
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014
The feature of BCG complications in children
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
Rapid monitoring of tuberculosis treatment response: A multi-centre study
Source: International Congress 2016 – Advances in tuberculosis diagnosis and monitoring of treatment
Year: 2016
Home based tuberculosis (TB) care program
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Modern social and clinical characteristics of miliary tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Immunodiagnosis of tuberculosis infection in children under the age of five - Which testing is feasible?
Source: International Congress 2015 – Paediatric bronchology
Year: 2015
Experience of using diaskintest in adult patients with tuberculosis and non-tuberculosis respiratory diseases in a regional TB hospital
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
Statin use and the risk of tuberculosis: Data from 305,142 patients
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016
Impact of drug injection using on TB-AIDS treatment outcomes
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept